Master Protocol of TCR-modified T Cell Therapy Targeting HLA-restricted KRAS Antigen Administered in Adult Patients With Metastatic or Locally Advanced PDAC
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
PDAC
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Herlev and Gentofte University Hospital, Copenhagen, Denmark
Charité Universitätsmedizin Berlin, Berlin, Germany
Technische Universitaet Dresden - Universitaetsklinikum Carl Gustav Carus, Dresden, Germany
Universitaetsklinikum Heidelberg, Heidelberg, Germany
University Hospital and Faculty of Medicine Eberhard Karls University Tübingen, Tübingen, Germany
Amsterdam UMC - VU Medical Center, Amsterdam, Netherlands
Radboud University Medical Center, Nijmegen, Netherlands
Karolinska University Hospital, Stockholm, Sweden
Contact: Study coordinator (Maximiliam Kordes) · maximilian.kordes@regionstockholm.se · 08-123-83611